COMP <GO>
CWK vs BAC // PIOTROSKI F-SCORE QUALITY
Cushman & Wakefield Ltd. (NYSE) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: CWK 7
— BAC 4
■ METRIC PARITY
LAST: $13.30 (+1.45%) • MKT CAP: $3.08B
piotroski-score
7/9
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CWK VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CWK | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.40% | 2.50% | +6.90 | CWK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.0x | 30.2x | -20.20 | CWK | /valuation <GO> |
| Free Cash Flow Yield | 9.52% | 2.10% | +7.42 | CWK | /fcf-yield <GO> |
| Operating Margin | 4.40% | 32.90% | -28.50 | BAC | /operating-margins <GO> |
| Net Profit Margin | 0.90% | 27.00% | -26.10 | BAC | /net-margins <GO> |
| Revenue Growth (YoY) | 8.90% | 6.80% | +2.10 | CWK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.73 | 0.45 | +1.28 | CWK | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.60% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.4 | 27.7 | +37.72 | CWK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.90 | +0.01 | CWK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.5x | 10.9x | +21.60 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.08B | $357.61B | -$354.53B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CWK REV | BAC REV | CWK GROSS % | BAC GROSS % | CWK FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.29B | $113.10B | 44.0% | 44.0% | $293.0M | $7.52B |
| FY 2024 | $9.45B | $105.86B | 44.0% | 44.0% | $167.0M | -$13.57B |
| FY 2023 | $9.49B | $102.77B | 44.0% | 44.0% | -$275.0M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CWK // BETA 0.91
BAC // BETA 0.90